10% Discount on Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market (Valid till 30th Sept 2016)

About This Presentation
Title:

10% Discount on Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market (Valid till 30th Sept 2016)

Description:

Bharat Book Bureau provides the report, on "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment”. This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. – PowerPoint PPT presentation

Number of Views:12

less

Transcript and Presenter's Notes

Title: 10% Discount on Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market (Valid till 30th Sept 2016)


1
10 Discount (Valid till 30th Sept 2016)
Personalized Medicine, Targeted Therapeutics
Companion Diagnostic Market
2
Summary
  • This is a comprehensive account of the market
    size, segmentation, key players, SWOT analysis,
    influential technologies, and business and
    economic environments. The report is supported by
    over 360 tables figures over 393 pages. The
    personalized medicine (global USA) market is
    presented as follows By Company (e.g.,
    Qiagen, AFFYMETRIX, ATOSSA GENETICS, NODALITY,
    deCode /Amgen, CELERA, MYRIAD)
  • By Segment (Targeted therapeutics, Companion
    Diagnostics, Liquid Biopsies)
  • By Sub-market (Companion diagnostic, targeted
    cancer therapeutic, medical technology,
    pharmacogenomics, consumer genomics, molecular
    diagnostics, liquid biopsy) By Therapy (Cancer,
    Cardiovascular, Infectious Disease)

3
A wealth of financial data business strategy
  • Company financials, sales revenue figures
    Business Model Strategies for Diagnostic,
    Pharmaceutical and Biotechnology Companies
    Business Model Strategies for Providers. Provider
    Systems and Academic Medical Centre Business
    Model Strategies for Payers Governments
    Private and Public Funding and Personalized
    Medicine Reimbursement  Revisions to Current
    Payment Systems and intellectual property How
    to Gain Market Penetration in the EU

4
SWOT, Economic Regulatory Environment
  • Key strengths, weaknesses and threats
    influencing leading player position Top
    fastest growing market segments and emerging
    opportunities Top pharmaceutical companies
    within the IPM by market share and revenue
    Comprehensive product portfolios, RD activity
    and pipeline therapeutics  MA activity and
    future strategies of top personalized medicine
    pharmacos Personalized Medicine Regulation
    (USA, UK, Germany, France, Spain, Italy)
    CE-marked Personalized Medicine/Diagnostic Tests

5
(No Transcript)
6
What you will gain
  • An in-depth understanding of the global
    personalized medicine market and its
    environment Current market facts, figures and
    product lines of key players in the industry
    Emerging trends in key markets such as the US,
    UK, Germany and France Technical insights into
    new generation sequencing technologies and
    ultra-high throughput sequencing FDA approved
    pharmacogenetic tests and recognized biomarkers

7
Who should read this report?
  • Pharmaceutical, biotechnology and diagnostic
    companies with an interest in personalized
    medicine Industry professionals and business
    strategists will discover key information to
    propel their policies Investors will gain
    inside information to dominant players in the
    industry Scientists will get a business
    perspective and industry insight into how
    scientific breakthroughs influence the market
    environment

8
Executive Summary
  • Cutting-edge new research by KellySciPub
    indicates that the core personalized medicine
    market will be worth over 149 billion by 2020
    with a CAGR of 8.74. This market is made up of
    companion diagnostics and targeted therapeutics
    and is dominated by oncology, cardiovascular and
    infectious disease treatment and diagnostics.
  • The report Personalized Medicine, Targeted
    Therapeutics and Companion Diagnostic Market
    Strategic Analysis of Industry Trends,
    Technologies, Participants, and Environment has
    already been procured by 21 of the top 25 Pharma
    companies globally. This newly published edition
    gives a revolutionary insight into the vertical
    growing market of personalized healthcare
    globally.

9
Table Of Content
  • Executive Summary
  • Introduction and Background
  • Personalized Medicine Targeted Therapeutics and
    Associated Companion Diagnostics
  • Personalized Medicine and Integration into the
    Healthcare System
  • Private and Public Funding and Personalized
    Medicine Reimbursement
  • European Personalized Medicine Market
    Payments and Investment
  • Personalized Medicine Business Model Analysis
  • Personalized Medicine Main Industry Players

10
Contact Us
  • Full Report Personalized Medicine Market Report
  • Bharat Book Bureau
  • Tel 91 22 27810772 / 27810773
  • Email poonam_at_bharatbook.com
  • Website www.bharatbook.com
  • FaceBook BharatBook3B
  • Twitter ResearchBook
  • LinkedIn Bharat Book Bureau
Write a Comment
User Comments (0)